383 related articles for article (PubMed ID: 33646645)
1. Covid-19 and oral diseases: Crosstalk, synergy or association?
Brandini DA; Takamiya AS; Thakkar P; Schaller S; Rahat R; Naqvi AR
Rev Med Virol; 2021 Nov; 31(6):e2226. PubMed ID: 33646645
[TBL] [Abstract][Full Text] [Related]
2. Oral manifestations of Covid-19-A literature review.
Farid H; Khan M; Jamal S; Ghafoor R
Rev Med Virol; 2022 Jan; 32(1):e2248. PubMed ID: 34028129
[TBL] [Abstract][Full Text] [Related]
3. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects.
Drozdzik A; Drozdzik M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163355
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2, periodontal pathogens, and host factors: The trinity of oral post-acute sequelae of COVID-19.
Schwartz J; Capistrano KJ; Gluck J; Hezarkhani A; Naqvi AR
Rev Med Virol; 2024 May; 34(3):e2543. PubMed ID: 38782605
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 impact on oral health: A general view.
Parra-Ortega I; Rodriguez-Ortega D
Bol Med Hosp Infant Mex; 2021 Jan; 78(2):91-94. PubMed ID: 33497372
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections.
Naqvi AR; Schwartz J; Brandini DA; Schaller S; Hussein H; Valverde A; Naqvi RA; Shukla D
Int Rev Immunol; 2022; 41(4):423-437. PubMed ID: 34525891
[TBL] [Abstract][Full Text] [Related]
7. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models.
Egilmezer E; Rawlinson WD
Rev Med Virol; 2021 Nov; 31(6):e2227. PubMed ID: 33763936
[TBL] [Abstract][Full Text] [Related]
8. Oral manifestations of COVID-19: Brief review.
Paradowska-Stolarz AM
Dent Med Probl; 2021; 58(1):123-126. PubMed ID: 33590976
[TBL] [Abstract][Full Text] [Related]
9. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection of the oral cavity and saliva.
Huang N; Pérez P; Kato T; Mikami Y; Okuda K; Gilmore RC; Conde CD; Gasmi B; Stein S; Beach M; Pelayo E; Maldonado JO; Lafont BA; Jang SI; Nasir N; Padilla RJ; Murrah VA; Maile R; Lovell W; Wallet SM; Bowman NM; Meinig SL; Wolfgang MC; Choudhury SN; Novotny M; Aevermann BD; Scheuermann RH; Cannon G; Anderson CW; Lee RE; Marchesan JT; Bush M; Freire M; Kimple AJ; Herr DL; Rabin J; Grazioli A; Das S; French BN; Pranzatelli T; Chiorini JA; Kleiner DE; Pittaluga S; Hewitt SM; Burbelo PD; Chertow D; ; ; Frank K; Lee J; Boucher RC; Teichmann SA; Warner BM; Byrd KM
Nat Med; 2021 May; 27(5):892-903. PubMed ID: 33767405
[TBL] [Abstract][Full Text] [Related]
11. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
Fuentes-Prior P
J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
[TBL] [Abstract][Full Text] [Related]
12. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of "the New Normal with COVID-19".
Imai K; Tanaka H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207046
[TBL] [Abstract][Full Text] [Related]
14. An update on oral clinical courses among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A clinical follow-up (a prospective prevalent cohort) study.
Gebretsadik HG
PLoS One; 2022; 17(10):e0275817. PubMed ID: 36269692
[TBL] [Abstract][Full Text] [Related]
15. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and its effects on neurological functions.
Yew MMT; Lip JQ; Ling APK
Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117
[TBL] [Abstract][Full Text] [Related]
17. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
[TBL] [Abstract][Full Text] [Related]
18. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?
Brandão TB; Gueiros LA; Melo TS; Prado-Ribeiro AC; Nesrallah ACFA; Prado GVB; Santos-Silva AR; Migliorati CA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Feb; 131(2):e45-e51. PubMed ID: 32888876
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
20. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
